|
Dec 24
|
Chief Medical Officer Niranjan Kanesa-thasan Sells 11,884 Shares of Icosavax Inc (ICVX)
|
|
Dec 8
|
Wall Street Analysts Believe Icosavax, Inc. (ICVX) Could Rally 175.87%: Here's is How to Trade
|
|
Dec 4
|
Icosavax, Inc. (ICVX) is on the Move, Here's Why the Trend Could be Sustainable
|
|
Aug 8
|
Icosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination Potential
|